Dr. Kwak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# Falk
Pittsburgh, PA 15213Phone+1 412-648-6401Fax+1 412-648-6399
Summary
- I am a board certified Infectious Diseases physician specializing in management of Infectious issues in transplant recipients.
Education & Training
- McGill University Faculty of MedicineClass of 1996, MD
Certifications & Licensure
- PA State Medical License 2001 - 2024
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Prospective Evaluations of Infectious Complication in Lung Transplant Recipients Start of enrollment: 2006 Aug 01
- A Retrospective Review of Infections Usually Observed in Transplant Recipients Start of enrollment: 2006 Aug 01
Publications & Presentations
PubMed
- 40 citationsIsavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.Palash Samanta, Cornelius J. Clancy, Rachel V Marini, Ryan M. Rivosecchi, Erin K McCreary
Clinical Infectious Diseases. 2021-08-02 - 18 citationsImpact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes.Sarah Taimur, Stephanie M Pouch, Nicole Zubizarreta, Madhu Mazumdar, Meenakshi Rana
Clinical Transplantation. 2021-02-08 - 284 citationsEffect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized C...Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti
Infectious Diseases and Therapy. 2018-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: